Cargando…

Association between Inflammatory Conditions and Alzheimer’s Disease Age of Onset in Down Syndrome

Adults with Down syndrome (DS) have an exceptionally high prevalence of Alzheimer disease (AD), with an earlier age of onset compared with the neurotypical population. In addition to beta amyloid, immunological processes involved in neuroinflammation and in peripheral inflammatory/autoimmune conditi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lai, Florence, Mercaldo, Nathaniel, Wang, Cassandra M., Hersch, Giovi G., Rosas, Herminia Diana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307987/ https://www.ncbi.nlm.nih.gov/pubmed/34300282 http://dx.doi.org/10.3390/jcm10143116

Ejemplares similares

Association between Hypothyroidism Onset and Alzheimer Disease Onset in Adults with Down Syndrome
por: Lai, Florence, et al.
Publicado: (2021)

Altered connectivity of the default mode network in cognitively stable adults with Down syndrome: “Accelerated aging” or a prelude to Alzheimer's disease?
por: Rosas, H. Diana, et al.
Publicado: (2021)

Association of Dilated Perivascular Spaces and Disease Severity in Patients With Huntington Disease
por: Chan, Suk Tak, et al.
Publicado: (2021)

Impaired Cerebrovascular Reactivity in Huntington’s Disease
por: Chan, Suk Tak, et al.
Publicado: (2021)

Sex differences in risk of Alzheimer's disease in adults with Down syndrome
por: Lai, Florence, et al.
Publicado: (2020)

Cognitive Function during the Prodromal Stage of Alzheimer’s Disease in Down Syndrome: Comparing Models
por: Hom, Christy L., et al.
Publicado: (2021)

Evidence that PICALM affects age at onset of Alzheimer's dementia in Down syndrome
por: Jones, Emma L., et al.
Publicado: (2013)

Correction: Hom et al. Cognitive Function during the Prodromal Stage of Alzheimer’s Disease in Down Syndrome: Comparing Models. Brain Sci. 2021, 11, 1220
por: Hom, Christy L., et al.
Publicado: (2022)

Cerebrospinal fluid biomarkers of Alzheimer's disease in a cohort of adults with Down syndrome
por: Henson, Rachel L., et al.
Publicado: (2020)

Polymorphisms in BACE2 may affect the age of onset Alzheimer's dementia in Down syndrome()
por: Mok, Kin Y., et al.
Publicado: (2014)

The Alzheimer's Biomarker Consortium‐Down Syndrome: Rationale and methodology
por: Handen, Benjamin L., et al.
Publicado: (2020)

Timing of Alzheimer’s Disease by Intellectual Disability Level in Down Syndrome
por: Hartley, Sigan L., et al.
Publicado: (2023)

Monoaminergic impairment in Down syndrome with Alzheimer's disease compared to early-onset Alzheimer's disease
por: Dekker, Alain D., et al.
Publicado: (2017)

The amyloid plaque proteome in early onset Alzheimer’s disease and Down syndrome
por: Drummond, Eleanor, et al.
Publicado: (2022)

Proteomic profiles for Alzheimer's disease and mild cognitive impairment among adults with Down syndrome spanning serum and plasma: An Alzheimer's Biomarker Consortium–Down Syndrome (ABC–DS) study
por: Petersen, Melissa E., et al.
Publicado: (2020)

The age of onset and evolution of Braak tangle stage and Thal amyloid pathology of Alzheimer’s disease in individuals with Down syndrome
por: Davidson, Yvonne S., et al.
Publicado: (2018)

The Association between Physical Activity and CAMDEX-DS Changes Prior to the Onset of Alzheimer’s Disease in Down Syndrome
por: Pape, Sarah E., et al.
Publicado: (2021)

Predictors of Age of Diagnosis and Survival of Alzheimer’s Disease in Down Syndrome
por: Sinai, Amanda, et al.
Publicado: (2017)

Developmental deficits and staging of dynamics of age associated Alzheimer’s disease neurodegeneration and neuronal loss in subjects with Down syndrome
por: Wegiel, Jerzy, et al.
Publicado: (2022)

Obstructive sleep apnea, cerebrovascular disease, and amyloid in older adults with Down syndrome across the Alzheimer’s continuum
por: Lao, Patrick, et al.
Publicado: (2022)

Individualized estimated years from onset of Alzheimer's disease– related decline for adults with Down syndrome
por: Silverman, Wayne, et al.
Publicado: (2023)

Language skills as a predictor of cognitive decline in adults with Down syndrome
por: Pulsifer, Margaret B., et al.
Publicado: (2020)

Neuroinflammation in the Aging Down Syndrome Brain; Lessons from Alzheimer's Disease
por: Wilcock, Donna M.
Publicado: (2012)

Aging related cognitive changes associated with Alzheimer's disease in Down syndrome
por: Firth, Nicholas C., et al.
Publicado: (2018)

Characteristics of Adults with Down Syndrome: Prevalence of Age-Related Conditions
por: Carfì, Angelo, et al.
Publicado: (2014)

Conditions of negation formation in children of early age with down syndrome
por: Sedova, E., et al.
Publicado: (2021)

An Intron 7 Polymorphism in APP Affects the Age of Onset of Dementia in Down Syndrome
por: Jones, Emma L., et al.
Publicado: (2010)

Down’s syndrome, neuroinflammation, and Alzheimer neuropathogenesis
por: Wilcock, Donna M, et al.
Publicado: (2013)

Distribution and age of onset of psychopathological risk in a cohort of children with Down syndrome in developmental age
por: Marino, M., et al.
Publicado: (2019)

Dynamics of plasma biomarkers in Down syndrome: the relative levels of Aβ42 decrease with age, whereas NT1 tau and NfL increase
por: Mengel, David, et al.
Publicado: (2020)

The CREST-E study of creatine for Huntington disease: A randomized controlled trial
por: Hersch, Steven M., et al.
Publicado: (2017)

Joint‐label fusion brain atlases for dementia research in Down syndrome
por: Queder, Nazek, et al.
Publicado: (2022)

What can we learn from study of Alzheimer's disease in patients with Down syndrome for early-onset Alzheimer's disease in the general population?
por: Wallace, Robyn A, et al.
Publicado: (2011)

Complex spatial and temporally defined myelin and axonal degeneration in Huntington disease
por: Rosas, H.D., et al.
Publicado: (2018)

Polymorphisms in HSD17B1: Early Onset and Increased Risk of Alzheimer's Disease in Women with Down Syndrome
por: Lee, Joseph H., et al.
Publicado: (2012)

Detection of Brain Tau Pathology in Down Syndrome Using Plasma Biomarkers
por: Janelidze, Shorena, et al.
Publicado: (2022)

To Sleep to Dream … No More? The Quest for Restorative Sleep in Huntington’s Disease, a Clinician’s Perspective
por: Rosas, Herminia Diana
Publicado: (2023)

Aging and Down Syndrome
por: Head, Elizabeth, et al.
Publicado: (2012)

β-Secretases, Alzheimer's Disease, and Down Syndrome
por: Webb, Robin L., et al.
Publicado: (2012)

Cerebrovascular pathology in Down syndrome and Alzheimer disease
por: Head, Elizabeth, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_57k46rq7126d4l8vi2dhpefm4v